BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8247943)

  • 1. [Possible role of serotonin in hemostatic the mechanism of action of desmopressin (DDAVP) in patients with uremia].
    Małyszko J; Małyszko J; Pietraszek M; Azzadin A; Myśliwiec M; Buczko W
    Pol Arch Med Wewn; 1993 Aug; 90(2):105-11. PubMed ID: 8247943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study on mechanisms of a haemostatic effect of 1 deamino-8-D-arginine vasopressin (desmopressin) in uraemic patients.
    Malyszko J; Pietraszek M; Buczko W; Mysliwiec M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(2):319-24. PubMed ID: 1697836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DDAVP releases tPA in correlation with a fall in platelet serotonin in uraemic patients.
    Malyszko J; Malyszko JS; Azzadin A; Mysliwiec M; Buczko W
    Thromb Res; 1992 Nov; 68(3):303-8. PubMed ID: 1471076
    [No Abstract]   [Full Text] [Related]  

  • 4. Desmopressin: a nontransfusional hemostatic agent.
    Mannucci PM
    Annu Rev Med; 1990; 41():55-64. PubMed ID: 2184748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Desmopressin-induced improvement in bleeding times in chronic renal failure patients correlates with platelet serotonin uptake and ATP release.
    Soslau G; Schwartz AB; Putatunda B; Conroy JD; Parker J; Abel RF; Brodsky I
    Am J Med Sci; 1990 Dec; 300(6):372-9. PubMed ID: 2264575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of desmopressin on hemostasis in patients with liver cirrhosis.
    Agnelli G; Parise P; Levi M; Cosmi B; Nenci GG
    Haemostasis; 1995; 25(5):241-7. PubMed ID: 7489963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uremic plasma after infusion of desmopressin (DDAVP) improves the interaction of normal platelets with vessel subendothelium.
    Escolar G; Cases A; Monteagudo J; Garrido M; Lopez J; Ordinas A; Revert L; Castillo R
    J Lab Clin Med; 1989 Jul; 114(1):36-42. PubMed ID: 2738447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Desmopressin induces decrease in platelet serotonin content in uremia.
    Małyszko J; Pietraszek MH; Azzadin A; Buczko W; Myśliwiec M
    Thromb Haemost; 1989 Jun; 61(3):537. PubMed ID: 2799766
    [No Abstract]   [Full Text] [Related]  

  • 9. Hemostatic and fibrinolytic response to desmopressin in uremic patients.
    Chen KS; Huang CC; Leu ML; Deng P; Lo SK
    Blood Purif; 1997; 15(2):84-91. PubMed ID: 9087815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Desmopressin (DDAVP) and hemostasis.
    Lethagen S
    Ann Hematol; 1994 Oct; 69(4):173-80. PubMed ID: 7948303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of desmopressin (DDAVP) on protein C and protein C inhibitors in uremia.
    Akpolat T; Ozdemir O; Arik N; Demirkan F; Sungur C; Ozcebe O; Dündar S; Yasavul U; Turgan C; Kirazli S
    Nephron; 1993; 64(2):232-4. PubMed ID: 8321356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conjugated estrogens shorten bleeding time in uraemia: a possible role of serotonin?
    Malyszko JS; Malyszko J; Azzadin A; Buczko W; Mysliwiec M
    Thromb Haemost; 1995 Jan; 73(1):164-5. PubMed ID: 7740490
    [No Abstract]   [Full Text] [Related]  

  • 13. Desmopressin (DDAVP) for treatment of disorders of hemostasis.
    Mannucci PM
    Prog Hemost Thromb; 1986; 8():19-45. PubMed ID: 3104987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Desmopressin improves platelet dysfunction measured by in vitro closure time in uremic patients.
    Lee HK; Kim YJ; Jeong JU; Park JS; Chi HS; Kim SB
    Nephron Clin Pract; 2010; 114(4):c248-52. PubMed ID: 20090366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonergic mechanisms are involved in the hemostatic action of erythropoietin in uremic patients.
    Malyszko J; Mazerska M; Malyszko J; Pawlak K; Azzadin A; Mysliwiec M; Buczko W
    Int J Clin Lab Res; 1993; 23(1):42-4. PubMed ID: 8477092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemostatic and fibrinolytic response to nasal desmopressin in hemodialysis patients.
    Ulusoy S; Ovali E; Aydin F; Erem C; Ozdemir F; Kaynar K
    Med Princ Pract; 2004; 13(6):340-5. PubMed ID: 15467309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Desmopressin stimulates the expression of P-selectin on human platelets in vitro.
    Wun T; Paglieroni TG; Lachant NA
    J Lab Clin Med; 1995 Oct; 126(4):401-9. PubMed ID: 7561450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Desmopressin in the treatment of hemorrhagic diathesis].
    Haar D; Hasselbalch HC
    Ugeskr Laeger; 1995 Nov; 157(48):6713-5. PubMed ID: 8540136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subcutaneous desmopressin (DDAVP) shortens the bleeding time in uremia.
    Viganò GL; Mannucci PM; Lattuada A; Harris A; Remuzzi G
    Am J Hematol; 1989 May; 31(1):32-5. PubMed ID: 2705441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of desmopressin on hemostatic parameters in the normal dog.
    Johnstone IB; Crane S
    Can J Vet Res; 1986 Apr; 50(2):265-71. PubMed ID: 3093039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.